Article info

Download PDFPDF
Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy

Authors

  • Nopasak Phasukkijwatana Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California, USA Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  • Anna C S Tan Vitreous Retina Macula Consultants of New York, New York, New York, USA LuEsther T Mertz Retinal Research Center, Manhattan, Eye, Ear and Throat Hospital, New York, New York, USA Singapore National Eye Center/Singapore Eye Research Institute, Singapore PubMed articlesGoogle scholar articles
  • Xuejing Chen Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • K Bailey Freund Vitreous Retina Macula Consultants of New York, New York, New York, USA LuEsther T Mertz Retinal Research Center, Manhattan, Eye, Ear and Throat Hospital, New York, New York, USA PubMed articlesGoogle scholar articles
  • David Sarraf Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California, USA Greater Los Angeles VA Healthcare Center, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr David Sarraf, Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA; dsarraf{at}ucla.edu
View Full Text

Citation

Phasukkijwatana N, Tan ACS, Chen X, et al
Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy

Publication history

  • Received April 4, 2016
  • Revised May 19, 2016
  • Accepted July 14, 2016
  • First published August 8, 2016.
Online issue publication 
April 22, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.